SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-17-347420
Filing Date
2017-11-20
Accepted
2017-11-20 06:09:28
Documents
3
Period of Report
2018-01-05

Document Format Files

Seq Description Document Type Size
1 PRE 14A d484656dpre14a.htm PRE 14A 1347805
2 GRAPHIC g484656g52o40.jpg GRAPHIC 262249
3 GRAPHIC g484656g76m77.jpg GRAPHIC 36166
  Complete submission text file 0001193125-17-347420.txt   1759938
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-34637 | Film No.: 171212565
SIC: 2834 Pharmaceutical Preparations